Find Esomeprazole Strontium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

122 RELATED EXCIPIENT COMPANIES

219EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: S-omeprazole strontium hydrate, Fm0f67, Esomeprazole strontium [usan], 934714-36-0, Fm-0f67, C5n25h3803
Molecular Formula
C34H44N6O10S2Sr
Molecular Weight
848.5  g/mol
InChI Key
NCGHIAKEJNQSMS-QLGOZJDFSA-N
FDA UNII
C5N25H3803

Esomeprazole Strontium
The S-isomer of omeprazole.
1 2D Structure

Esomeprazole Strontium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
strontium;5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;tetrahydrate
2.1.2 InChI
InChI=1S/2C17H18N3O3S.4H2O.Sr/c2*1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;;;;;/h2*5-8H,9H2,1-4H3;4*1H2;/q2*-1;;;;;+2/t2*24-;;;;;/m00...../s1
2.1.3 InChI Key
NCGHIAKEJNQSMS-QLGOZJDFSA-N
2.1.4 Canonical SMILES
CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.O.O.O.O.[Sr+2]
2.1.5 Isomeric SMILES
CC1=CN=C(C(=C1OC)C)C[S@](=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)C[S@](=O)C2=NC3=C([N-]2)C=CC(=C3)OC.O.O.O.O.[Sr+2]
2.2 Other Identifiers
2.2.1 UNII
C5N25H3803
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Esomeprazole

2. Esomeprazole Magnesium

3. Esomeprazole Potassium

4. Esomeprazole Sodium

5. Esomeprazole Strontium Anhydrous

6. Nexium

7. Strontium, Esomeprazole

2.3.2 Depositor-Supplied Synonyms

1. S-omeprazole Strontium Hydrate

2. Fm0f67

3. Esomeprazole Strontium [usan]

4. 934714-36-0

5. Fm-0f67

6. C5n25h3803

7. (-)-5-methoxy-2-((s)-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1h- Benzimidazole Strontium Salt Tetrahydrate

8. 1h-benzimidazole, 6-methoxy-2-((s)-((4-methoxy-3,5-dimethyl-2-pyridinyl) Methyl)sulfinyl)-, Strontium Salt, Hydrate (2:1:4)

9. Esomeprazole Strontium (usan)

10. Strontium;5-methoxy-2-[(s)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;tetrahydrate

11. Unii-c5n25h3803

12. Esomeprazole Strontium (tn)

13. Esomeprazole Strontium Hydrate

14. Chembl2146140

15. Hip1601

16. Esomeprazole Strontium Tetrahydrate

17. Hip-1601

18. Esomeprazole Strontium [vandf]

19. Esomeprazole Strontium [usp-rs]

20. Esomeprazole Strontium [who-dd]

21. Esomeprazole Strontium [orange Book]

22. Esomeprazole Strontium [usp Monograph]

23. D10120

24. Q27275225

2.4 Create Date
2007-05-07
3 Chemical and Physical Properties
Molecular Weight 848.5 g/mol
Molecular Formula C34H44N6O10S2Sr
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count18
Rotatable Bond Count10
Exact Mass848.16164622 g/mol
Monoisotopic Mass848.16164622 g/mol
Topological Polar Surface Area167 Ų
Heavy Atom Count53
Formal Charge0
Complexity453
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count7
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameEsomeprazole strontium
PubMed HealthEsomeprazole
Drug ClassesGastric Acid Secretion Inhibitor, Gastrointestinal Agent
Drug LabelThe active ingredient in the proton pump inhibitor esomeprazole strontium delayed-release capsules is bis(5methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-1-yl)strontium tetrahydrate. Esomeprazole is the S...
Active IngredientEsomeprazole strontium
Dosage FormCapsule, delayed release
RouteOral
Strengtheq 40mg base; eq 20mg base
Market StatusPrescription
CompanyHanmi Pharm

2 of 2  
Drug NameEsomeprazole strontium
PubMed HealthEsomeprazole
Drug ClassesGastric Acid Secretion Inhibitor, Gastrointestinal Agent
Drug LabelThe active ingredient in the proton pump inhibitor esomeprazole strontium delayed-release capsules is bis(5methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-1-yl)strontium tetrahydrate. Esomeprazole is the S...
Active IngredientEsomeprazole strontium
Dosage FormCapsule, delayed release
RouteOral
Strengtheq 40mg base; eq 20mg base
Market StatusPrescription
CompanyHanmi Pharm

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)


Proton Pump Inhibitors

Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - 24.6...DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - 24.65MG

USFDA APPLICATION NUMBER - 202342

read-more

DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - 49.3...DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - 49.3MG

USFDA APPLICATION NUMBER - 202342

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Co-Processed Excipients

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Empty Capsules

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Coloring Agents

read-more
read-more

Emulsifying Agents

read-more
read-more

Topical

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Granulation

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty